Christopher Bowden
2017
In 2017, Christopher Bowden earned a total compensation of $2.3M as Chief Medical Officer at Agios Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,571 |
|---|---|
| Option Awards | $1,639,353 |
| Salary | $449,174 |
| Other | $8,710 |
| Total | $2,330,808 |
Bowden received $1.6M in option awards, accounting for 70% of the total pay in 2017.
Bowden also received $233.6K in non-equity incentive plan, $449.2K in salary and $8.7K in other compensation.
Rankings
In 2017, Christopher Bowden's compensation ranked 4,774th out of 14,666 executives tracked by ExecPay. In other words, Bowden earned more than 67.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,774 out of 14,666 | 67th |
Division Manufacturing | 1,692 out of 5,772 | 71st |
Major group Chemicals And Allied Products | 496 out of 2,075 | 76th |
Industry group Drugs | 382 out of 1,731 | 78th |
Industry Pharmaceutical Preparations | 303 out of 1,333 | 77th |
Source: SEC filing on April 18, 2018.
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2017.
News
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2021 pay slips 14% to $6.5M
April 28, 2022
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2020 pay falls 54% to $7.6M
April 8, 2021
Agios Pharmaceuticals CEO Jacqualyn Fouse receives $17M in 2019
April 16, 2020
Agios Pharmaceuticals CEO David Schenkein's 2018 pay jumps 37% to $8.2M
April 18, 2019